Neuroimaging & Brain MeasuresPsilocybin

Comparing neural correlates of consciousness: from psychedelics to hypnosis and meditation

This comparative neuroimaging study (n=107) compares the neural correlates of two pharmacological methods, psilocybin (n=23) and LSD (n=25), and two non-pharmacological methods, hypnosis (n=30) and meditation (n=29), in inducing altered states of consciousness (ASC). The results reveal distinct connectivity patterns associated with pharmacological and non-pharmacological interventions, predictability at an individual level, and unique behavioural-neural relationships between psilocybin and LSD, all contributing to a broader understanding of the mechanisms of ASC and their potential therapeutic applications in psychiatric disorders.

Authors

  • Nathalie Rieser

Published

Biological Psychiatry
individual Study

Abstract

Background

Pharmacological and non-pharmacological methods of inducing altered states of consciousness (ASC) are becoming increasingly relevant in the treatment of psychiatric disorders. While comparisons between them are often drawn, to date no study has directly compared their neural correlates.

Methods

To address this knowledge gap we directly compared two pharmacological methods: psilocybin (n=23, dose=0.2mg/kg p.o.) and LSD (n=25, dose=100μg p.o.) and two non-pharmacological methods: hypnosis (n=30) and meditation (n=29) using resting state functional connectivity magnetic resonance imaging (rs-fcMRI), and assessed the predictive value of the data using a machine learning approach.

Results

We found that (i) no network reaches significance in all four ASC methods; (ii) pharmacological and non-pharmacological interventions of inducing ASC show distinct connectivity patterns that are predictive at the individual level; (iii) hypnosis and meditation show differences in functional connectivity when compared directly, and also drive distinct differences when jointly compared to the pharmacological ASC interventions; (iv) psilocybin and LSD show no differences in functional connectivity when directly compared to each other, but do show distinct behavioral-neural relationships.

Conclusion

Overall, these results extend our understanding of the mechanisms of action of ASC and highlight the importance of exploring how these effects can be leveraged in the treatment of psychiatric disorders.

Available with Blossom Pro

Research Summary of 'Comparing neural correlates of consciousness: from psychedelics to hypnosis and meditation'

Introduction

Moujaes and colleagues frame altered states of consciousness (ASC) — whether pharmacologically induced (psychedelics) or produced by non-pharmacological means (hypnosis, meditation) — as increasingly relevant to psychiatric treatment. Earlier research has documented phenomenological overlap across different ASC and begun to map neural correlates of psychedelic states, but direct, whole-brain, data-driven comparisons across pharmacological and non-pharmacological ASC remain scarce. The authors note additional gaps: many hypnosis and meditation studies use seed-based analyses that vary in region selection and thus hinder cross-study comparisons, and links between neural changes and behavioural measures of ASC have been relatively neglected. This study aims to fill those gaps by directly comparing two classic psychedelics (psilocybin and LSD) with two non-pharmacological methods (an imagery-based form of hypnosis termed 'Esdaile' and open-awareness meditation). The investigators set out to (i) identify whole-brain neural correlates of each ASC using resting-state functional connectivity MRI, (ii) assess differences between pharmacological and non-pharmacological methods, (iii) test whether connectivity changes are predictive at the individual level with machine learning, and (iv) conduct a preliminary analysis linking ASC-induced behavioural changes to neural connectivity alterations.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

  • Study Type
    individual
  • Journal
  • Compound
  • Topic
  • Author
  • APA Citation

    Moujaes, F., Rieser, N. M., Phillips, C., de Matos, N. M., Brügger, M., Dürler, P., Smigielski, L., Stämpfli, P., Seifritz, E., Vollenweider, F. X., Anticevic, A., & Preller, K. H. (2024). Comparing neural correlates of consciousness: from psychedelics to hypnosis and meditation. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 9(5), 533-543. https://doi.org/10.1016/j.bpsc.2023.07.003

References (19)

Papers cited by this study that are also in Blossom

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Carhart-Harris, R. L., Bolstridge, M., Rucker, J. et al. · Lancet Psychiatry (2016)

1174 cited
Psychedelics, meditation, and self-consciousness

Milliere, R., Carhart-Harris, R. L., Roseman, L. et al. · Frontiers in Psychology (2018)

Psychedelics and hypnosis: Commonalities and therapeutic implications

Lemercier, C. E., Terhune, D. B. · Journal of Psychopharmacology (2021)

Serotonergic Hallucinogen-Induced Visual Perceptual Alterations

Kometer, M., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)

Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin

Lebedev, A. V., L€ Ovd En, M., Rosenthal, G. et al. · Human Brain Mapping (2015)

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin

Mason, N. L., Kuypers, K. P. C., Reckweg, J. et al. · Neuropsychopharmacology (2020)

Acute effects of lysergic acid diethylamide in healthy subjects

Schmid, Y., Enzler, F., Gasser, P. et al. · Biological Psychiatry (2015)

Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders

Vollenweider, F. X., Preller, K. H. · Nature Reviews Neuroscience (2020)

The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors

De Gregorio, D., Posa, L., Ochoa-Sanchez, R. et al. · Pharmacological Research (2016)

Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens

Halberstadt, A. L., Geyer, M. A. · Neuropharmacology (2011)

Show all 19 references
The pharmacology of lysergic acid diethylamide: a review

Passie, T., Halpern, J. H., Stichtenoth, D. O. et al. · CNS Neuroscience and Therapeutics (2008)

Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

Madsen, M. K., Fisher, P. M., Burmester, D. et al. · Neuropsychopharmacology (2019)

The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation

Preller, K. H., Herdener, M., Pokorny, T. et al. · Current Biology (2017)

Psychometric evaluation of the altered states of consciousness rating scale (OAV)

Studerus, E., Gamma, A., Vollenweider, F. X. · PLOS ONE (2010)

Neural Correlates of the Shamanic State of Consciousness

Pasquini, L., Luke, D., Harris, R. E. et al. · Frontiers in Human Neuroscience (2021)

Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat

Smigielski, L., Kometer, M., Scheidegger, M. et al. · Scientific Reports (2019)

126 cited
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies

Studerus, E., Kometer, M., Hasler, F. et al. · Journal of Psychopharmacology (2010)

423 cited

Cited By (2)

Papers in Blossom that reference this study

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.